CONCORD DRUGS
Back to Cashflow Statement
|
CONCORD DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.02 Cr | ₹0.07 Cr | ₹0.02 Cr | ₹0.01 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.02 Cr |
| Mar2024 | ₹0.07 Cr |
| Mar2023 | ₹0.02 Cr |
| Mar2022 | ₹0.01 Cr |
How is Net Cash Inflow / Outflow of CONCORD DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.02 Cr | Negative | |
| Mar2024 | ₹0.07 Cr | 204.55 | |
| Mar2023 | ₹0.02 Cr | 144.44 | |
| Mar2022 | ₹0.01 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD DRUGS | ₹96.3 Cr | 2.5% | 2.2% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
CONCORD DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD DRUGS | 2.5% |
2.2% |
0.6% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses